Table 1 Baseline characteristics of study participants (n = 27)

Age, years

51.23 ± 27.24

Sex, male

16/27 (59.3%)

BMI, kg/m²

20.85 ± 4.84

MDRO carriage

 VRE

15 (55.5%)

 CPE

1 (3.7%)

 VRE/CPE

11 (40.7%)

Antibiotic resistance gene

 VanA

26 (68.4%)

 bla_KPC

11 (28.9%)

 bla_OXA

1 (2.6%)

 bla_NDM

0

Duration of carriage before FMT, days

71.00 ± 88.00

Antibiotics use before FMT within 1 week

16 (59.3%)

Antibiotics use after FMT within 1 week

17 (62.9%)

Laboratory test at FMT

 WBC count, 10³/μL

6.88 ± 2.53

 Haemoglobin, g/dL

10.68 ± 1.48

 Platelet count, 10³/μL

293.32 ± 138.38

 BUN, mg/dL

15.07 ± 12.78

 Creatinine, mg/dL

15.07 ± 12.78

 AST, IU/L

37.20 ± 31.51

 ALT, IU/L

23.36 ± 15.59

 Total cholesterol, mg/dL

161.12 ± 54.55

 LDL cholesterol, mg/dL

94.32 ± 40.48

 Albumin, mg/dL

3.38 ± 0.51

 Fasting glucose, mg/dL

108.24 ± 39.94

 CRP, mg/L

13.61 ± 13.71